TITLE

Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update

AUTHOR(S)
Genest, Jacques; Frohlich, Jiri; Fodor, George; McPherson, Ruth
PUB. DATE
October 2003
SOURCE
CMAJ: Canadian Medical Association Journal;10/28/2003, Vol. 169 Issue 9, p921
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents the guidelines developed by the Working Group on Hypercholesterolemia and Other Dyslipidemias for the management and treatment of dyslipidemias in Canada. Factors influencing risk assessment; Diagnosis of asymptomatic atherosclerosis; List of lipid-lowering medications.
ACCESSION #
11105975

 

Related Articles

  • Atherosclerosis: an Athero-Thrombo-Inflammatory Disease. Manolis, Antonis S.; Manolis, Theodora A.; Melita, Helen // Hospital Chronicles;2012, Vol. 7 Issue 4, p195 

    Classical risk factors for the development of atherosclerosis include hypercholesterolemia, hypertension, smoking, and diabetes. When the atheromatous plaque erodes or ruptures, local thrombosis develops which leads to partial or complete vessel occlusion with its attendant potentially...

  • Effects of Atorvastatin Treatment on sICAM-1 and Plasma Nitric Oxide Levels in Hypercholesterolemic Subjects. Sardo, Maria A.; Castaldo, Maria; Cinquegrani, Maurizio; Bonaiuto, Michele; Maesano, Antonella; Versace, Antonio; Spadaro, Miriam; Campo, Salvatore; Nicocia, Giaconio; Altavilla, Domenica; Saitta, Antonino // Clinical & Applied Thrombosis/Hemostasis;Jul2002, Vol. 8 Issue 3, p257 

    This study investigated the behavior of soluble intercellular adhesion molecule-1 (sICAM-1) and serum nitric oxide (NO) products, nitrite/nitrate (NO2-/NO3-), in subjects with primary hypercholesterolemia (HCh) without other risk factors and atherosclerosis. The effect of a short-term...

  • Hyperlipidemia is Associated with Altered Levels of Insulin-Like Growth Factor-I. MALÍK, J.; ŠTULC, T.; WICHTERLE, D.; MELENOVSKÝ, V.; CHYTILOVÁ, E.; LACINOVÁ, Z.; MAREK, J.; ČEŠKA, R. // Physiological Research;2008, Vol. 57 Issue 6, p919 

    Previous studies revealed altered levels of the circulating insulinlike growth factor-I (IGF-I) and of its binding protein-3 (IGFBP-3) in subjects with coronary atherosclerosis, metabolic syndrome and premature atherosclerosis. Hyperlipidemia is a powerful risk factor of atherosclerosis. We...

  • A Study on Regression of Hypercholesterolemic Atherosclerosis in Rabbits by Flax Lignan Complex. Prasad, Kailash // Journal of Cardiovascular Pharmacology & Therapeutics;Dec2007, Vol. 12 Issue 4, p304 

    The article discusses a study on regression of hypercholesterolemic atherosclerosis in rabbits by flax lignan complex. Hyperlipidemia and increased oxidative stress were found to be associated with atherosclerosis in rabbits with 0.25 percent cholesterol diet. Reductions in serum lipids and...

  • EXPERIMENTAL AORTIC ATHEROSCLEROSIS IN RABBITS FOLLOWING THE INGESTION OF DIHYDROCHOLESTEROL. Sieracki, Joseph C.; Beher, W. T.; Baker, G. D. // Angiology;Aug1960, Vol. 11 Issue 4, p343 

    Ingested dihydrocholesterol, a constant companion of cholesterol, is atherogenic in rabbits. The atherosrlerosis is different from that seen in cholesterol fed rabbits. The histologic sequence of events in these lesions over a 51-week period is described in some detail. The lesions occurred in...

  • Simvastatin-induced changes in circulating oxidized low-density lipoprotein in different types of dyslipidemia. Tavridou, Anna; Efthimiadis, Apostolos; Efthimiadis, Ioannis; Manolopoulos, Vangelis G. // Heart & Vessels;Jul2010, Vol. 25 Issue 4, p288 

    Beyond lowering lipid levels, 3-hydroxy-3-methyl glutaryl coenzyme A reductase inhibitors (statins) have been shown to possess antioxidant properties, which may explain some of their beneficial effects in reducing atherosclerosis. We sought to determine whether circulating oxidized low-density...

  • Familial hypercholesterolaemia. Phillips, T.; Leigh, I. M. // Journal of the Royal Society of Medicine;Oct1987, Vol. 80 Issue 10, p649 

    The article presents information on a case about familial hypercholesterolemia. This condition has been considered rare as it occurs in only one in a million of the population. The disease is characterized by cutaneous xanthomata, tendon xanthomata, arcus senilis, atherosclerosis with angina and...

  • cholesteremia, cholesterolemia.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p439 

    An encyclopedia entry for "cholesteremia" or "cholesterolemia" is presented.

  • Plasma High-Density Lipoproteins and Ischemic Heart Disease. Streja, Dan; Steiner, George; Kwiterovich, Peter O. // Annals of Internal Medicine;Dec78, Vol. 89 Issue 6, p871 

    Investigates the signs of familial hypercholesterolemia in a Newfoundland kindred. Description of primary hyperbetalipoproteinemia; Interrelationships of plasma high-density lipoprotein cholesterol levels and other plasma lipids and lipoproteins and the presence of ischemic heart disease;...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics